Results from an observational study conducted by researchers at the UCLA's Jonsson Comprehensive Cancer Center shows that prostate cancer patients who undergo robot-assisted radical prostatectomy (RARP) or robotic-assisted prostate surgery have fewer instances of cancer cells at the edge of their surgical specimen and less need for additional cancer treatments like hormone or radiation therapy than patients who have traditional open radical prostatectomy (ORP) or "open"…Continue
Added by Editorial Team on February 28, 2014 at 3:30pm — No Comments
Scientists ar the University of Houston,a Carnegie-designated Tier One public research university, are working to develop the next generation of prostate cancer therapies, which are targeted at metabolism. With approximately one out of six American men being diagnosed and nearly a quarter of a million new cases expected this year, prostate cancer is the most common malignancy among men in the United States.
Standard of care
Since prostate cancer relies…
Added by Editorial Team on February 27, 2014 at 11:00pm — No Comments
A new study, published online in the January 21, 2014 edition of Breast Cancer Research and Treatment, affirms that that the prognostic value of the 70-gene prognosis signature (MammaPrint®; Agendia) breast cancer test can accurately stratify a woman’s breast cancer risk for up to 25 years after she is first diagnosed with the disease.
In the article, a team of American and Dutch researchers report on the longest-term…Continue
Added by Editorial Team on February 27, 2014 at 5:00pm — No Comments
New research from Memorial Sloan Kettering, the world's oldest and largest private cancer center, provides fresh insight into the biologic mechanisms that individual cancer cells use to metastasize to the brain. Published in the February 27, 2014 issue of Cell, the study found that tumor cells that reach the brain — and successfully grow into new tumors — hug capillaries and express specific proteins that overcome the brain's…Continue
Added by Editorial Team on February 27, 2014 at 4:30pm — No Comments
Data presented at the 2014 Annual Bone Marrow Transplant (BMT) Tandem Meetings organized by The American Society for Blood and Marrow Transplantation and the Center for International Blood & Marrow Transplant Research being held in Grapevine (Dallas), Texas, February 26 - March 2, 2014, highlights the benefits of brentuximab vedotin (Adcetris®; Seattle Genetics) in various treatment schedules for hard to treat…Continue
Added by Editorial Team on February 27, 2014 at 2:30pm — No Comments
By Evelyn Griggs (Contributing Author)
A new study published in medical journal, PLoS One, has revealed that the use of human insulin is not associated with an increased risk for bladder cancer. The study, carried out by Chin-Hsiao Tseng and colleagues at the National Taiwan University College of Medicine, involved …Continue
Added by Editorial Team on February 27, 2014 at 2:00pm — No Comments
A vaccine targeting tumors that produce a certain protein and receptor responsible for communication between cells and the body's immune system, could initiate the immune response to fight cancer. These findings, published in the February 27, 2014 online edition of the journal Gene Therapy, build on previously reported research and could lead to new treatments for cancer.
The study's principal investigator John Morris, MD, clinical co-leader of the Molecular Therapeutics and…Continue
Added by Editorial Team on February 27, 2014 at 12:30pm — No Comments
Given the large numbers of long-term survivors, comorbid conditions have become increasingly relevant for breast cancer care. Especially older women who have overcome breast cancer are likely to struggle with heart disease, osteoporosis and hypertension further on in their lives. Whether these conditions occur or not is influenced by the treatment that patients have received in their fight against cancer, their overall weight and their age. Breast cancer survivors therefore should watch…Continue
Added by Editorial Team on February 26, 2014 at 8:30pm — No Comments
According to a multidisciplinary team led by University of Pittsburgh Cancer Institute (UPCI) scientists, invasive lobular carcinoma,the second-most common type of breast cancer, is a very different disease than the most common form and appears to be a good candidate for a personalized approach to treatment.
Invasive lobular carcinoma or ILC (photo 1), also called infiltrating lobular carcinoma, which is…Continue
Added by Editorial Team on February 26, 2014 at 5:30pm — No Comments
According to the Centers for Disease Control and Prevention (CDC), colorectal-cancer is the second leading cause of cancer death in the United States. Yet one in three adults is not adequately screened. Latinos have an exceptionally low rates of screening. A 2012 CDC survey found that 66% of non-Latino whites were adequately screened, compared to 53% of Latinos and 37% of uninsured patients. However, screening rates increased by nearly…Continue
Added by Editorial Team on February 26, 2014 at 2:00pm — No Comments
A new analysis of a study in young adults with thyroid cancer shows that adolescents and young adults who develop thyroid cancer as a secondary cancer have a significantly greater risk of dying than those with primary thyroid cancer. Published in the of the February 24, 2014 edition of Cancer, a peer-reviewed journal of the American Cancer Society (ACS), the findings stress the importance of screening young cancer survivors to detect early signs of a potentially life-threatening thyroid…Continue
Added by Editorial Team on February 24, 2014 at 2:00pm — No Comments
Ongoing medical research shows that targeted gene therapy may help in developing future treatments of cancer. However, accurate identification of the appropriate candidates gene/pathways for a targeted therapy is crucial for success. Researchers have found that the identification of genes that are significantly enriched in a group of patients with a specific cancer versus a control group is one way in developing a successful approach. This approach does, however, not work when there are…Continue
Added by Editorial Team on February 24, 2014 at 10:30am — No Comments
Taking dietary supplements is not without risk. While many people believe that that taking dietary and herbal supplements is good for our health, the truth is that they aren't benign. Supplements, whether theu are in the form of pills, lozenges, drinks or powders, they may have strong effects or our health. What's more, supplements can also interact with prescription medicines, which can lead to potentially dangerous - and lethal - reactions.
A multi-center study led by…Continue
Added by Editorial Team on February 21, 2014 at 2:30pm — No Comments
A new study published in the New England Journal of Medicine reports on a multi-site research project by Bradley J. Monk, MD and coworkers at the University of Arizona Cancer Center at St. Joseph's Hospital and Medical Center in Phoenix, Arizona. The results of their study expected to change the standard of care for women with…Continue
Added by Editorial Team on February 21, 2014 at 1:00pm — No Comments
Patients who received daily humidification of the mouth and throat region starting at day one of radiation therapy treatment spent nearly 50% fewer days in the hospital to manage their side effects, according to research presented today at the 2014 Multidisciplinary Head and Neck Cancer Symposium being held at the JW Marriott Camelback Inn Resort & Spa in Scottsdale, Arizona, February 20 - 22, 2014.
The study was conducted by the Trans Tasman Radiation Oncology…Continue
Added by Editorial Team on February 20, 2014 at 8:00pm — No Comments
A retrospective analysis of oropharyngeal cancer patients with recurrence of disease after primary therapy in the Radiation Therapy Oncology Group (RTOG) studies 0129 or 0522 found that HPV-positive patients had a higher overall survival (OS) rate than HPV-negative patients. The data, presented at the 2014 Multidisciplinary Head and Neck Cancer Symposium, being held at the JW Marriott Camelback Inn Resort & Spa in Scottsdale, Arizona, February 20 - 22, 2014, showed that at two years…Continue
Added by Editorial Team on February 20, 2014 at 6:00pm — No Comments
According to research presented at the 2014 Multidisciplinary Head and Neck Cancer Symposium, being held at the JW Marriott Camelback Inn Resort & Spa in Scottsdale, Arizona, February 20 - 22, 2014, patients with head and neck cancer undergoing radiation therapy, may benefit from a reduction in the amount of radiation treatment volume to the submandibular (level IB) lymph nodes. The study results showed a better patient-reported salivary function. Furthermore, the researchers also…Continue
Added by Editorial Team on February 20, 2014 at 1:00pm — No Comments
Pancreatic ductal adenocarcinoma or PDA is notoriously impervious to treatment and resists both chemotherapy and radiotherapy. It has also been thought to provide few targets for immune cells, allowing tumors to grow unchecked. But new research from Fred Hutchinson Cancer Research Center shows that pancreas cancer "veils" itself from the immune system by recruiting specialized immune suppressor cells. The research team also found that removing these cells quickly triggers a…Continue
Added by Editorial Team on February 20, 2014 at 12:30pm — No Comments
Combining Mutant-Allele Tumor Heterogeneity (MATH) as a biomarker with the patient’s HPV status provides an effective indicator of improved patient outcome, according to research presented at the 2014 Multidisciplinary Head and Neck Cancer Symposium being held at the JW Marriott Camelback Inn Resort & Spa in Scottsdale, Arizona, February 20 - 22, 2014. This interpretation is based on an evaluation of next-generation sequencing (NGS) data and associated clinical records of head and…Continue
Added by Editorial Team on February 20, 2014 at 12:00pm — No Comments
Epidemiological evidence from numerous studies show that neuropsychiatric or central nervous system (CNS) disorders may protect against cancer. For example, patients with alzheimer's disease, parkinson and schizophrenia have a lower than expected probability of developing some types of cancer. One of the most remarkable example is alzheimer's disease. The available data suggest that patients with alzheimer's disease have a reduced the risk - up to 50% less - of suffering from cancer.…Continue
Added by Editorial Team on February 20, 2014 at 11:30am — No Comments